Načítá se...
Entecavir downregulates interleukin-37 in patients with chronic active hepatitis B infection
OBJECTIVES: Interleukin-37 (IL-37) has been identified as a potent inhibitor of the immune response. This study aimed to examine IL-37 expression in patients with chronic active hepatitis B (CAHB), and explore its possible regulatory role during inflammation. METHODS: Peripheral blood mononuclear ce...
Uloženo v:
| Vydáno v: | J Int Med Res |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7254606/ https://ncbi.nlm.nih.gov/pubmed/31939340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060519884157 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|